Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Frequently asked questions
What sector does Curanex Pharmaceuticals Inc Common Stock (CURX) operate in?
Curanex Pharmaceuticals Inc Common Stock belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Curanex Pharmaceuticals Inc Common Stock (CURX) current stock price?
As of the latest data, Curanex Pharmaceuticals Inc Common Stock stock price is $0.22, with a previous close of $0.22. Curanex Pharmaceuticals Inc Common Stock lost -$0.00 in the last trading session, representing a -0.91% loss.
What is Curanex Pharmaceuticals Inc Common Stock (CURX) current market capitalization?
Curanex Pharmaceuticals Inc Common Stock market cap is approximately 6.16 million.
What is Curanex Pharmaceuticals Inc Common Stock (CURX) Earnings Per Share (EPS)?
The trailing EPS is -$0.02.
What is Curanex Pharmaceuticals Inc Common Stock (CURX) EBITDA?
Curanex Pharmaceuticals Inc Common Stock EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -3.15 million.
Does Curanex Pharmaceuticals Inc Common Stock (CURX) pay dividends?
No. Curanex Pharmaceuticals Inc Common Stock does not pay a dividend.
When is Curanex Pharmaceuticals Inc Common Stock (CURX) next earnings report?
Curanex Pharmaceuticals Inc Common Stock is expected to release its next earnings report on June 30, 2026.
What is Curanex Pharmaceuticals Inc Common Stock (CURX) beta (volatility) score?
Curanex Pharmaceuticals Inc Common Stock has a beta of -0.365, indicating lower volatility than the overall market.
